Drug interactions for the following drug(s)

Interactions between your selected drugs

The metabolism of Hydralazine can be decreased when combined with Metoprolol.

The metabolism of Atorvastatin can be decreased when combined with Trazodone.

The risk or severity of QTc prolongation can be increased when Trazodone is combined with Salbutamol.

The metabolism of Metoprolol can be decreased when combined with Trazodone.

Salbutamol may decrease the excretion rate of Hydralazine which could result in a higher serum level.

The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin glargine.

The risk or severity of QTc prolongation can be increased when Trazodone is combined with Fluoxetine.

Alogliptin may increase the hypoglycemic activities of Insulin glargine.

Pantoprazole can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy.

Pantoprazole may decrease the excretion rate of Alogliptin which could result in a higher serum level.

The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Amlodipine.

Pantoprazole may decrease the excretion rate of Salbutamol which could result in a higher serum level.

The risk or severity of bradycardia can be increased when Amlodipine is combined with Metoprolol.

Metformin may decrease the excretion rate of Hydralazine which could result in a higher serum level.

The risk or severity of QTc prolongation can be increased when Trazodone is combined with Amlodipine.

Pantoprazole may decrease the excretion rate of Metformin which could result in a higher serum level.

The risk or severity of QTc prolongation can be increased when Amlodipine is combined with Fluoxetine.

The metabolism of Pantoprazole can be decreased when combined with Fluoxetine.

Pantoprazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.

The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.

Amlodipine may increase the hypotensive activities of Hydralazine.

The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Fluoxetine.

The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Salbutamol.

The therapeutic efficacy of Alogliptin can be increased when used in combination with Furosemide.

The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Furosemide.

Pantoprazole may decrease the excretion rate of Metoprolol which could result in a higher serum level.

The risk or severity of hypokalemia can be increased when Furosemide is combined with Salbutamol.

The therapeutic efficacy of Salbutamol can be decreased when used in combination with Metoprolol.

Furosemide may increase the hypotensive activities of Amlodipine.

The serum concentration of Alogliptin can be increased when it is combined with Fluoxetine.

Trazodone may decrease the antihypertensive activities of Hydralazine.

The metabolism of Alogliptin can be decreased when combined with Metoprolol.

Pantoprazole may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.

Metformin may decrease the excretion rate of Salbutamol which could result in a higher serum level.

The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Alogliptin.

Trazodone may decrease the antihypertensive activities of Furosemide.

The risk or severity of adverse effects can be increased when Insulin glargine is combined with Metformin.

The metabolism of Atorvastatin can be decreased when combined with Hydralazine.

The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Metformin.

The therapeutic efficacy of Insulin glargine can be increased when used in combination with Metoprolol.

Furosemide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.

The therapeutic efficacy of Metformin can be increased when used in combination with Metoprolol.

The risk or severity of adverse effects can be increased when Furosemide is combined with Polyethylene glycol.

Salbutamol may decrease the antihypertensive activities of Amlodipine.

The metabolism of Fluoxetine can be increased when combined with Insulin glargine.

Metformin may increase the hypolipidaemic activities of Atorvastatin.

Metoprolol may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.

The excretion of Atorvastatin can be decreased when combined with Pantoprazole.

The metabolism of Alogliptin can be decreased when combined with Trazodone.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Drug1 (rxcui = 905395, name = hydralazine hydrochloride 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydralazine, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Hydralazine and Metoprolol.

Drug1 (rxcui = 856377, name = trazodone hydrochloride 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 617310, name = atorvastatin 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to trazodone, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Trazodone and Atorvastatin.

Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 856377, name = trazodone hydrochloride 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to trazodone and interaction asserted in DrugBank between Salbutamol and Trazodone.

Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 856377, name = trazodone hydrochloride 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to trazodone and interaction asserted in DrugBank between Metoprolol and Trazodone.

Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 905395, name = hydralazine hydrochloride 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to hydralazine and interaction asserted in DrugBank between Salbutamol and Hydralazine.

Drug1 (rxcui = 308135, name = amlodipine 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 311041, name = insulin glargine 100 UNT/ML Injectable Solution, tty = SCD). Drug1 is resolved to amlodipine, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Amlodipine and Insulin glargine.

Drug1 (rxcui = 310385, name = fluoxetine 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 856377, name = trazodone hydrochloride 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to fluoxetine, Drug2 is resolved to trazodone and interaction asserted in DrugBank between Fluoxetine and Trazodone.

Drug1 (rxcui = 311041, name = insulin glargine 100 UNT/ML Injectable Solution, tty = SCD). Drug2 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to insulin glargine, Drug2 is resolved to alogliptin and interaction asserted in DrugBank between Insulin glargine and Alogliptin.

Drug1 (rxcui = 310325, name = ferrous sulfate 325 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 251872, name = pantoprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to ferrous sulfate, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Ferrous sulfate anhydrous and Pantoprazole.

Drug1 (rxcui = 251872, name = pantoprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to pantoprazole, Drug2 is resolved to alogliptin and interaction asserted in DrugBank between Pantoprazole and Alogliptin.

Drug1 (rxcui = 308135, name = amlodipine 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 876193, name = polyethylene glycol 3350 17000 MG Powder for Oral Solution, tty = SCD). Drug1 is resolved to amlodipine, Drug2 is resolved to polyethylene glycol 3350 and interaction asserted in DrugBank between Amlodipine and Polyethylene glycol.

Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 251872, name = pantoprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Salbutamol and Pantoprazole.

Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 308135, name = amlodipine 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to amlodipine and interaction asserted in DrugBank between Metoprolol and Amlodipine.

Drug1 (rxcui = 905395, name = hydralazine hydrochloride 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydralazine, Drug2 is resolved to metformin and interaction asserted in DrugBank between Hydralazine and Metformin. Drug1 is resolved to hydralazine, Drug2 is resolved to alogliptin and interaction asserted in DrugBank between Hydralazine and Alogliptin.

Drug1 (rxcui = 856377, name = trazodone hydrochloride 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 308135, name = amlodipine 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to trazodone, Drug2 is resolved to amlodipine and interaction asserted in DrugBank between Trazodone and Amlodipine.

Drug1 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 251872, name = pantoprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to metformin, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Metformin and Pantoprazole.

Drug1 (rxcui = 310385, name = fluoxetine 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 308135, name = amlodipine 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to fluoxetine, Drug2 is resolved to amlodipine and interaction asserted in DrugBank between Fluoxetine and Amlodipine.

Drug1 (rxcui = 310385, name = fluoxetine 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 251872, name = pantoprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to fluoxetine, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Fluoxetine and Pantoprazole.

Drug1 (rxcui = 905395, name = hydralazine hydrochloride 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 251872, name = pantoprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to hydralazine, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Hydralazine and Pantoprazole.

Drug1 (rxcui = 310385, name = fluoxetine 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to fluoxetine, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Fluoxetine and Metoprolol.

Drug1 (rxcui = 905395, name = hydralazine hydrochloride 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 308135, name = amlodipine 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydralazine, Drug2 is resolved to amlodipine and interaction asserted in DrugBank between Hydralazine and Amlodipine.

Drug1 (rxcui = 310385, name = fluoxetine 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 876193, name = polyethylene glycol 3350 17000 MG Powder for Oral Solution, tty = SCD). Drug1 is resolved to fluoxetine, Drug2 is resolved to polyethylene glycol 3350 and interaction asserted in DrugBank between Fluoxetine and Polyethylene glycol.

Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 310385, name = fluoxetine 20 MG Oral Capsule, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to fluoxetine and interaction asserted in DrugBank between Salbutamol and Fluoxetine.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to alogliptin and interaction asserted in DrugBank between Furosemide and Alogliptin. Drug1 is resolved to furosemide, Drug2 is resolved to metformin and interaction asserted in DrugBank between Furosemide and Metformin.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 311041, name = insulin glargine 100 UNT/ML Injectable Solution, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Furosemide and Insulin glargine.

Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 251872, name = pantoprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Metoprolol and Pantoprazole.

Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to furosemide and interaction asserted in DrugBank between Salbutamol and Furosemide.

Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Salbutamol and Metoprolol.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 308135, name = amlodipine 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to amlodipine and interaction asserted in DrugBank between Furosemide and Amlodipine.

Drug1 (rxcui = 310385, name = fluoxetine 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to fluoxetine, Drug2 is resolved to alogliptin and interaction asserted in DrugBank between Fluoxetine and Alogliptin. Drug1 is resolved to fluoxetine, Drug2 is resolved to metformin and interaction asserted in DrugBank between Fluoxetine and Metformin.

Drug1 (rxcui = 905395, name = hydralazine hydrochloride 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 856377, name = trazodone hydrochloride 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydralazine, Drug2 is resolved to trazodone and interaction asserted in DrugBank between Hydralazine and Trazodone.

Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to alogliptin and interaction asserted in DrugBank between Metoprolol and Alogliptin.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 251872, name = pantoprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Furosemide and Pantoprazole.

Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to metformin and interaction asserted in DrugBank between Salbutamol and Metformin. Drug1 is resolved to albuterol, Drug2 is resolved to alogliptin and interaction asserted in DrugBank between Salbutamol and Alogliptin.

Drug1 (rxcui = 308135, name = amlodipine 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to amlodipine, Drug2 is resolved to alogliptin and interaction asserted in DrugBank between Amlodipine and Alogliptin.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 856377, name = trazodone hydrochloride 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to trazodone and interaction asserted in DrugBank between Furosemide and Trazodone.

Drug1 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 311041, name = insulin glargine 100 UNT/ML Injectable Solution, tty = SCD). Drug1 is resolved to metformin, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Metformin and Insulin glargine.

Drug1 (rxcui = 905395, name = hydralazine hydrochloride 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 617310, name = atorvastatin 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydralazine, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Hydralazine and Atorvastatin.

Drug1 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 308135, name = amlodipine 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to metformin, Drug2 is resolved to amlodipine and interaction asserted in DrugBank between Metformin and Amlodipine.

Drug1 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 311041, name = insulin glargine 100 UNT/ML Injectable Solution, tty = SCD). Drug1 is resolved to metoprolol, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Metoprolol and Insulin glargine.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 905395, name = hydralazine hydrochloride 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to hydralazine and interaction asserted in DrugBank between Furosemide and Hydralazine.

Drug1 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to metformin, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Metformin and Metoprolol.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 876193, name = polyethylene glycol 3350 17000 MG Powder for Oral Solution, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to polyethylene glycol 3350 and interaction asserted in DrugBank between Furosemide and Polyethylene glycol.

Drug1 (rxcui = 630208, name = albuterol 0.83 MG/ML Inhalation Solution, tty = SCD). Drug2 (rxcui = 308135, name = amlodipine 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to albuterol, Drug2 is resolved to amlodipine and interaction asserted in DrugBank between Salbutamol and Amlodipine.

Drug1 (rxcui = 310385, name = fluoxetine 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 311041, name = insulin glargine 100 UNT/ML Injectable Solution, tty = SCD). Drug1 is resolved to fluoxetine, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Fluoxetine and Insulin glargine.

Drug1 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 617310, name = atorvastatin 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to metformin, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Metformin and Atorvastatin.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 866514, name = metoprolol tartrate 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to metoprolol and interaction asserted in DrugBank between Furosemide and Metoprolol.

Drug1 (rxcui = 251872, name = pantoprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 617310, name = atorvastatin 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to pantoprazole, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Pantoprazole and Atorvastatin.

Drug1 (rxcui = 856377, name = trazodone hydrochloride 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1368385, name = alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to trazodone, Drug2 is resolved to alogliptin and interaction asserted in DrugBank between Trazodone and Alogliptin.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.